Clinical Trial Update: BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting outcomes of a new dose of Betaferon/Betaseron (interferon beta-1b) in relapsing-remitting multiple sclerosis. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)
• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: COMPLETED